Effect of Zoledronic Acid on Reducing Femoral Bone Mineral Density Loss following Total Hip Arthroplasty Preliminary Results of a Prospective Randomized Trial

被引：29
|
作者：
Scott, David F. [1 ]
Woltz, Jennifer N. [1 ]
Smith, Rachel R. [1 ]
机构：
[1] Spokane Joint Replacement Ctr Inc, Spokane, WA 99218 USA
来源：
JOURNAL OF ARTHROPLASTY | 2013年 / 28卷 / 04期
关键词：
total hip arthroplasty; bone mineral density; bisphosphonates; X-RAY ABSORPTIOMETRY; PARTICLE-INDUCED OSTEOLYSIS; DOUBLE-BLIND; IMPLANT MIGRATION; ALENDRONATE; PAMIDRONATE; BISPHOSPHONATES; PREVENTION; RESORPTION;
D O I：
10.1016/j.arth.2012.08.007
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
This randomized trial evaluated the effect of zoledronic acid on femoral bone mineral density (BMD) following primary total hip arthroplasty. Bone mineral density was compared for up to 2 years in 27 patients receiving 5 mg zoledronic acid intravenous infusion and in 24 patients receiving placebo at 2 weeks and 1 year after surgery. Zoledronic acid prevented loss of bone mineral density at 1 year (+13.8% vs +1.4%, P=.0065) and 2years (+14.3% vs -4.0%, P<.0001) in Gruen zone 1, at 1 year (-8.4% vs -25.4%, P<.0001) and 2years (-9.6% vs -27.3%, P<.0001) in Gruen zone 7, at 6weeks, 6 months, and 1 or 2 years in Gruen zones 4 and 6. For all Gruen zones, prevention of BMD loss by ZOL was significant at 6weeks, 6 months, 1 year (+0.80% vs -6.03%, P<.0001) and 2years (-0.16% vs -7.13%, P<.0001). (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：671 / 675
页数：5
相关论文
共 50 条
  • [1] Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: A meta-analysis from randomized controlled trails
    Gao, Jian
    Gao, Chong
    Li, Hui
    Wang, Guo-sheng
    Xu, Chang
    Ran, Jian
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 47 : 116 - 126
  • [2] Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
    Huang, Tsan-Wen
    Wang, Chao-Jan
    Shih, Hsin-Nung
    Chang, Yuhan
    Huang, Kuo-Chin
    Peng, Kuo-Ti
    Lee, Mel S.
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [3] Changes of Femoral Periprosthetic Bone Mineral Density 6 Years after Treatment with Alendronate following Total Hip Arthroplasty
    Arabmotlagh, Mohammad
    Pilz, Mathias
    Warzecha, Joerg
    Rauschmann, Michael
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2009, 27 (02) : 183 - 188
  • [4] Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial
    Kobayashi, Naomi
    Inaba, Yutaka
    Uchiyama, Makoto
    Ike, Hiroyuki
    Kubota, So
    Saito, Tomoyuki
    JOURNAL OF ARTHROPLASTY, 2016, 31 (01) : 333 - 338
  • [5] Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: A systematic review and meta-analysis
    Ren, Liang
    Wang, Weidong
    MEDICINE, 2018, 97 (17)
  • [6] Effect of a stemless femoral implant for total hip arthroplasty on the bone mineral density of the proximal femur - A prospective longitudinal study
    Munting, E
    Smitz, P
    VanSante, N
    deDeuxchaisnes, CN
    Vincent, A
    Devogelaer, JP
    JOURNAL OF ARTHROPLASTY, 1997, 12 (04) : 373 - 379
  • [7] Larger Femoral Periprosthetic Bone Mineral Density Decrease Following Total Hip Arthroplasty for Femoral Neck Fracture Than for Osteoarthritis: A Prospective, Observational Cohort Study
    Mann, Tobias
    Eisler, Thomas
    Boden, Henrik
    Muren, Olle
    Stark, Andre
    Salemyr, Mats
    Skoldenberg, Olof
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2015, 33 (04) : 504 - 512
  • [8] Effect of zoledronic acid on bone mineral density in patients of celiac disease: A prospective, randomized, pilot study
    Kumar, Mukul
    Rastogi, Ashu
    Bhadada, Sanjay Kumar
    Bhansali, Anil
    Vaiphei, Kim
    Kochhar, Rakesh
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 138 : 882 - 887
  • [9] Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty A meta-analysis of randomized controlled trials
    Su, Jing
    Wei, Yi
    Li, Xiao Ming
    Diao, Yan-Ping
    Liu, Huai-Gang
    Zhang, Liang
    MEDICINE, 2018, 97 (51)
  • [10] Periprosthetic femoral bone loss in total hip arthroplasty: systematic analysis of the effect of stem design
    Knutsen, Ashleen R.
    Lau, Nicole
    Longjohn, Donald B.
    Ebramzadeh, Edward
    Sangiorgio, Sophia N.
    HIP INTERNATIONAL, 2017, 27 (01) : 26 - 34
12345